ReviewJournal of hematology & oncology2019

Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies.

Dongxu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.